Showing results (1871-1880 of 3,582) with videos related to

Sort By:
Pageof 359
Research Square|June 19, 2023
Looking under the lamp-post: quantifying the performance of contact tracing in the United States during the SARS-CoV-2 pandemicHenry Bayly, Madison Stoddard, Debra Van Egeren, et al.
Internal Medicine Journal|March 14, 2023
Omadacycline therapy for Mycobacterium abscessus species infectionsPaul R Ingram, Eva E Jones, Bethwyn Allen, et al.
Marine Pollution Bulletin|January 27, 2026
Recovery timeframe is a critical component in preserving carbon stocks in disturbed tropical seagrass meadowsTaylor Renee Condron, Timothy M Smith, Paul H York, et al.
Development Genes and Evolution|September 5, 2012
Snail-dependent repression of the RhoGEF pebble is required for gastrulation consistency in Drosophila melanogasterMichael J Murray, Tony D Southall, Wenjie Liu, et al.
The Journal of Rheumatology|July 24, 1998
Contrasting cytokine profiles in the synovium of different forms of juvenile rheumatoid arthritis and juvenile spondyloarthropathy: prominence of interleukin 4 in restricted diseaseK J Murray, A A Grom, S D Thompson, et al.
BMC Public Health|February 23, 2024
Looking under the lamp-post: quantifying the performance of contact tracing in the United States during the SARS-CoV-2 pandemicHenry Bayly, Madison Stoddard, Debra Van Egeren, et al.
Journal of Dual Diagnosis|December 20, 2025
Comparative Effectiveness of Long Acting Injectable Versus Oral Naltrexone in Patients with Co-Occurring Posttraumatic Stress Disorder and Alcohol Use DisorderLuke R Rozema, Eleanor J Murray, Bradley V Watts, et al.
Biochemistry|September 10, 2003
Do enzymes change the nature of transition states? Mapping the transition state for general acid-base catalysis of a serine proteaseRichard R Bott, Gina Chan, Blanca Domingo, et al.
Journal of the American Chemical Society|May 21, 2010
Highly-selective and reversible O2 binding in Cr3(1,3,5-benzenetricarboxylate)2Leslie J Murray, Mircea Dinca, Junko Yano, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 17, 2009
Pharmacodynamics of 2-[4-[(1E)-1-(hydroxyimino)-2,3-dihydro-1H-inden-5-yl]-3-(pyridine-4-yl)-1H-pyrazol-1-yl]ethan-1-ol (GDC-0879), a potent and selective B-Raf kinase inhibitor: understanding relationships between systemic concentrations, phosphorylated mitogen-activated protein kinase kinase 1 inhibition, and efficacyHarvey Wong, Marcia Belvin, Sylvia Herter, et al.
Pageof 359